ANTIGENICS INC /DE/
10-Q, EX-27, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ANTIGENICS INC /DE/, 10-Q, EX-10.1, 2000-08-14
Next: ANTIGENICS INC /DE/, 424B3, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE JUNE 30,
2000 UNAUDITED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                     105,140,814
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                           106,220,963
<PP&E>                                      10,306,406
<DEPRECIATION>                               2,077,705
<TOTAL-ASSETS>                             115,190,750
<CURRENT-LIABILITIES>                        2,778,082
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       247,951
<OTHER-SE>                                 110,462,633
<TOTAL-LIABILITY-AND-EQUITY>               115,190,750
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            11,819,855
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             204,737
<INCOME-PRETAX>                            (9,209,106)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (9,209,106)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (9,209,106)
<EPS-BASIC>                                     (0.39)
<EPS-DILUTED>                                   (0.39)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission